Plaintiff Law Firm Announces Results of Avandia Clinical Trials…
If two recent cases highlighting plaintiff’s lawyer’s abuse of medical experts was not enough, last week the Sanders Firm…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Eli Lilly’s William Chin to Head Harvard’s Research
While the growing trend with medical schools and hospitals around the country are to develop policies that “minimize the potential…
Billy Tauzin Leaving PhRMA
Last week, Billy Tauzin, a 66-year-old cancer survivor, and former Congressman from Louisiana, announced that he would be…
Cleveland Clinic Study of CME Bias Found No Evidence of Difference Between…
In a recent edition of the Journal of Academic Medicine, Steven Kawczak and William Carey of the Cleveland…
Why All the Pharmaceutical Lawsuits?
A recent article from the Washington Legal Foundation (WLF), examined the trend of “pharmaceutical manufacturers becoming the…
New Developments in Pharmaceutical Lawsuits – Attorneys Studies for Hire:…
A new development in the continuing trend of pharmaceutical company lawsuits occurred last week, when a “New Jersey appeals…
GlaxoSmithKline’s CEO Andrew Witty and His Work in Developing Nations:…
The recent trend of media and Congress to call drug and pharmaceutical companies the “bad guys,” like Wall Street and AIG, only…
Letters to the Editor: Conflict of Interest in Authorship, and Disclosure…
Last year, Laurence J. Hirsch, a former spokesman for the pharmaceutical manufacturer Merck, wrote an 11-page…
State Policy: New Jersey Senate Committee Passes Conflict of Interest…
Last week, the New Jersey Senate Health, Human Services and Senior Citizens Committee approved a bill—S-369—that will…
State Policy: Minnesota Clarifies Restrictions on Payments to Physicians
In response to recent joint hearings held by the Minnesota Commerce and Labor, and the Business, Industry and Jobs…